The study on physiologically vasoactive substances extracted from skeletal muscles of fur seal. II. Isolation, purification and pharmacological assessment of the substances.:II. Isolation, purification and pharmacological assessment of the substances
スポンサーリンク
概要
- 論文の詳細を見る
It has been reported that fraction I, still including an effective substance for the improvement of peripheral circulation and being non-adsorptive to resin, is fractionated by Amberlite XAD-2 resin chromatography from crude mixture, which is extracted from skeletal muscle of fur seals. Furthermore, fraction I was divided broadly into 4 fractions of A to D in compliance with electrical density in the ion exchange chromatography in this study. In each fraction, the extraction, the isolation and the identification of the substituent was investigated precisely in chemical and biological level. Results as follows:<BR>1) Fraction-A produced following actions which were a marked aggregative action in human platelet, increasing action in peripheral blood flow and temporary endothelium dependent relaxing action in isolated vessels. HPLC analysis identified the vasoactive substance in fraction A with 5′ ADP.<BR>2) As for fraction-B, a marked vasodilating action and inhibitory action of human platelet aggregation were observed. This active substance was identified to be 5′ AMP by HPLC analysis.<BR>3) A vasoactive action of the fraction-C was faint and it was chromatically confirmed to be containing carnosine and anserine in Fr. C.<BR>4) Fraction-D showed the strongest increase of a peripheral blood flow in comparison with any other fraction and produced a powerfull contraction in isolated vessels. This vasocontractive action was inhibited by antihistamine and H<SUB>1</SUB> receptor-antagonist so that it was considered to be caused by histamin like substance. The active substance was identified finally to be histamine by HPLC analysis.
- 日本歯科薬物療法学会の論文
日本歯科薬物療法学会 | 論文
- カンジダのバイオフィルム産生性に対する抗真菌薬の効果
- 当院における全身麻酔下手術中に使用された抗菌薬の15年間(1992-2006年)の推移
- 「顎骨骨髄炎に対する抗菌薬の効果判定基準」の解析結果
- 植物精油の口腔微生物に対する抗菌性およびバイオフィルム形成抑制効果の検討
- ニフェジピン歯肉増殖症患者の線維芽細胞に対する18α-グリチルレチン酸のアポトーシス誘導効果